News

DSM BioSolutions has entered into an agreement with Laboratoires Mayoly Spindler, Chatou Cedex, France, for the manufacture of ‘MS1819’ lipase. DSM has successfully completed process development and commenced

ARCA biopharma (ARCA) has submitted a study protocol for review under the FDA’s Special Protocol Assessment (SPA) process for the design of a clinical trial. The study is

Eli Lilly and Incyte have entered into an exclusive worldwide license and collaboration agreement for the development and commercialisation of Incyte’s oral JAK1/JAK2 inhibitor, INCB28050, and certain follow

Santarus has received the $20m milestone payment previously announced on December 1, 2009 relating to the approval of Zegerid OTC (omeprazole 20mg/sodium bicarbonate 1100mg capsules) under its over-the-counter

Eisai has presented results of the investigational compound, eritoran tetrasodium (E5564), where it appeared to be well tolerated in patients with severe sepsis in a phase II trial

Cpex Pharmaceuticals (Cpex) has completed enrollment in its ongoing phase 2a clinical trial of Nasulin, the company’s intranasal insulin candidate. Reportedly, the study was initiated in February of

PGxHealth, a division of Clinical Data, has entered into a research collaboration with Deutsches Herzzentrum (DHZ) to evaluate the predictive value of genetic markers, including PGxHealth proprietary markers,

Lupin has settled all ongoing Hatch-Waxman litigation relating to Memantine tablets, Lupin’s generic version of Forest Laboratories’ Alzheimer disease treatment, Namenda tablets. Namenda tablet is intended for the

Mettler Toledo, a manufacturer of precision instruments, has developed ‘Risk Check’, an online tool to analyze the weighing risk of balances from all kinds of manufacturers. Risk Check